105 related articles for article (PubMed ID: 19543329)
1. T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft.
Dubinsky AN; Burt RK; Martin R; Muraro PA
Bone Marrow Transplant; 2010 Feb; 45(2):325-31. PubMed ID: 19543329
[TBL] [Abstract][Full Text] [Related]
2. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution.
Packer AN; Muraro PA
Exp Hematol; 2007 Mar; 35(3):516-21. PubMed ID: 17309832
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.
Peggs KS; Verfuerth S; Pizzey A; Khan N; Moss P; Goldstone AH; Yong K; Mackinnon S
Biol Blood Marrow Transplant; 2003 Mar; 9(3):198-205. PubMed ID: 12652471
[TBL] [Abstract][Full Text] [Related]
4. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation.
O'keefe CL; Sobecks RM; Wlodarski M; Rodriguez A; Bell K; Kuczkowski E; Bolwell BJ; Maciejewski JP
Exp Hematol; 2004 Oct; 32(10):1010-22. PubMed ID: 15504556
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
6. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
7. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Muraro PA; Douek DC; Packer A; Chung K; Guenaga FJ; Cassiani-Ingoni R; Campbell C; Memon S; Nagle JW; Hakim FT; Gress RE; McFarland HF; Burt RK; Martin R
J Exp Med; 2005 Mar; 201(5):805-16. PubMed ID: 15738052
[TBL] [Abstract][Full Text] [Related]
8. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients.
Burt RK; Traynor AE; Cohen B; Karlin KH; Davis FA; Stefoski D; Terry C; Lobeck L; Russell EJ; Goolsby C; Rosen S; Gordon LI; Keever-Taylor C; Brush M; Fishman M; Burns WH
Bone Marrow Transplant; 1998 Mar; 21(6):537-41. PubMed ID: 9543056
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft.
Hirokawa M; Horiuchi T; Kawabata Y; Kitabayashi A; Miura AB
Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.
Sun W; Popat U; Hutton G; Zang YC; Krance R; Carrum G; Land GA; Heslop H; Brenner M; Zhang JZ
Brain; 2004 May; 127(Pt 5):996-1008. PubMed ID: 14985264
[TBL] [Abstract][Full Text] [Related]
11. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
12. Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.
Okamoto H; Arii C; Shibata F; Toma T; Wada T; Inoue M; Tone Y; Kasahara Y; Koizumi S; Kamachi Y; Ishida Y; Inagaki J; Kato M; Morio T; Yachie A
Clin Exp Immunol; 2007 Jun; 148(3):450-60. PubMed ID: 17374134
[TBL] [Abstract][Full Text] [Related]
13. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood.
Beck RC; Wlodarski M; Gondek L; Theil KS; Tuthill RJ; Sobeck R; Bolwell B; Maciejewski JP
Br J Haematol; 2005 May; 129(3):411-9. PubMed ID: 15842666
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
16. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
18. Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients.
Ni XS; Ouyang J; Zhu WH; Wang C; Chen B
Clin Transplant; 2006; 20(4):485-9. PubMed ID: 16842526
[TBL] [Abstract][Full Text] [Related]
19. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
20. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
